{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:32:04Z","timestamp":1769628724959,"version":"3.49.0"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1911,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2000,11]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Peripheral blood CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells, CD19<jats:sup>+<\/jats:sup>\/20<jats:sup>+<\/jats:sup> B cells, and serum immunoglobulins (Igs) have been implicated as survival factors for pediatric HIV\u20101 infection. To determine which of these immune factors might be important in predicting survival, we studied HIV\u20101 vertically infected (HIV\u20101<jats:sup>+<\/jats:sup>) children over a 5\u2010year period. Peripheral blood lymphocytes and Igs were measured in 298 HIV\u20101<jats:sup>+<\/jats:sup> children, who were classified as survivors or nonsurvivors, and in 463 HIV\u20101 vertically exposed and noninfected (HIV\u20101<jats:sup>\u2212<\/jats:sup>) children. Measurements of other possible survival factors were included in this study: albumin, hemoglobin, lactic dehydrogenase (LDH), and HIV\u20101 RNA levels. Survivors had significantly higher CD4<jats:sup>+<\/jats:sup> T\u2010cell, CD8<jats:sup>+<\/jats:sup> T\u2010cell, and CD19<jats:sup>+<\/jats:sup>\/CD20<jats:sup>+<\/jats:sup> B\u2010cell counts and serum IgG levels, but lower serum IgA and IgM levels than nonsurvivors. Serum albumin and blood hemoglobin levels were higher, but serum LDH and HIV\u20101 RNA levels were lower in the survivors compared to non\u2010survivors. In univariable analysis, factors affecting survival were baseline CD4<jats:sup>+<\/jats:sup> T\u2010cell and CD8<jats:sup>+<\/jats:sup> T\u2010cell counts, IgG, albumin, hemoglobin, LDH, and HIV\u20101 RNA (all <jats:styled-content><jats:italic>p<\/jats:italic> &lt; 0.001<\/jats:styled-content>). In multivariable analysis, high baseline CD4<jats:sup>+<\/jats:sup> T\u2010cell count, IgG and albumin levels, and low baseline HIV\u20101 RNA load remained important factors for survival. Serum IgG level has been identified as an immune factor that independently predicts survival, in addition to the already established CD4<jats:sup>+<\/jats:sup> T\u2010cell count. The HIV\u20101 RNA and serum albumin levels also predicted survival.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2000.tb05499.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T20:40:38Z","timestamp":1279658438000},"page":"298-312","source":"Crossref","is-referenced-by-count":15,"title":["Evaluation of Immune Survival Factors in Pediatric HIV\u20101 Infection"],"prefix":"10.1111","volume":"918","author":[{"given":"WILLIAM T.","family":"SHEARER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KIRK A.","family":"EASLY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JOHANNA","family":"GOLDFARB","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HAL B.","family":"JENSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HOWARD M.","family":"ROSENBLATT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREA","family":"KOVACS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KENNETH","family":"MCINTOSH","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"THE PC HIV STUDY GROUP","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"35","article-title":"Immunologic targets of HIV infection: T\u2010cells","volume":"693","author":"Shearer W.T.","year":"1993","journal-title":"NICHD IVIG Clinical Trial Group, and the NHLBI P2C2 Pediatric Pulmonary and Cardiac Complications of HIV Infection Study Group. Ann. N.Y. Acad. Sci."},{"issue":"19","key":"e_1_2_6_3_2","first-page":"1337","article-title":"Women and Infants Transmission Study Group","volume":"336","author":"Shearer W.T.","year":"1997","journal-title":"Viral load and disease progression in infants infected with human immunodeficiency virus type 1. N. Engl. J. Med."},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.10.756"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199901140-00005"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198509000-00005"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)80277-3"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006454-198805000-00006"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(85)80505-9"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80549-8"},{"key":"e_1_2_6_11_2","first-page":"24","article-title":"Pediatric acquired immunodeficiency syndrome: demonstration of B lymphocyte defects in vitro","volume":"4","author":"Pahwa S.","year":"1986","journal-title":"Diagn. Immunol."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200003100-00004"},{"key":"e_1_2_6_13_2","first-page":"133","article-title":"X\u2010linked hyper IgM","volume":"5","author":"Fuleihan R.L.","year":"1997","journal-title":"The immunologist"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199701000-00002"},{"key":"e_1_2_6_15_2","first-page":"216","article-title":"Prognosis of human immunodeficiency virus infection in children and adolescents","volume":"8","author":"Krasinski K.","year":"1989","journal-title":"Pediatr. Infect. Dis."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)91592-V"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)90987-3"},{"key":"e_1_2_6_18_2","first-page":"350","article-title":"Characteristics of children surviving to five years of age or older with vertically acquired human immune deficiency infection","volume":"6","author":"Kline M.W.","year":"1995","journal-title":"Pediatr. AIDS HIV Infect."},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.105.1.e9"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(96)00230-2"},{"issue":"12","key":"e_1_2_6_21_2","first-page":"1","article-title":"1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age","volume":"43","author":"Centers for Disease Control and Prevention.","year":"1994","journal-title":"Morbid. Mortal. Wkly. Rep."},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.13.1542"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1086\/314764"},{"key":"e_1_2_6_24_2","first-page":"77","article-title":"Cytomegalovirus infection and HIV\u20101 disease progression in infants born to HIV\u20101\u2010infected women","volume":"341","author":"Kovacs A.","year":"1999","journal-title":"Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N. Engl. J. Med."},{"key":"e_1_2_6_25_2","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/clin.1994.1047","article-title":"Subpopulations of T and B cells in perinatally infected and non\u2010infected age\u2010matched children compared to those in adults","volume":"71","author":"Ibegbu C.H.","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb26287.x"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199108000-00008"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70247-7"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1086\/315672"},{"key":"e_1_2_6_30_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1128\/CDLI.6.2.247-253.1999","article-title":"Predictive value of CD19 measurements for bacterial infections in children infected with human immunodeficiency virus","volume":"6","author":"Betensky R.A.","year":"1999","journal-title":"Clin. Diag. Lab. Immunol."},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2000.105315"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2000.tb05499.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2000.tb05499.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T23:26:08Z","timestamp":1695684368000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2000.tb05499.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["10.1111\/j.1749-6632.2000.tb05499.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb05499.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}